Newbury Pharmaceuticals AB (OSTO:NEWBRY) FCF Margin % : -254.45% (As of Feb. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Newbury Pharmaceuticals AB's Free Cash Flow for the three months ended in Feb. 2024 was kr-7.98 Mil. Newbury Pharmaceuticals AB's Revenue for the three months ended in Feb. 2024 was kr3.14 Mil. Therefore, Newbury Pharmaceuticals AB's FCF Margin % for the quarter that ended in Feb. 2024 was -254.45%.

As of today, Newbury Pharmaceuticals AB's current FCF Yield % is -35.24%.

The historical rank and industry rank for Newbury Pharmaceuticals AB's FCF Margin % or its related term are showing as below:

OSTO:NEWBRY' s FCF Margin % Range Over the Past 10 Years
Min: -959.77 Med: -714.27 Max: -113.1
Current: -113.1

During the past 3 years, the highest FCF Margin % of Newbury Pharmaceuticals AB was -113.10%. The lowest was -959.77%. And the median was -714.27%.

OSTO:NEWBRY's FCF Margin % is ranked worse than
90.14% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.13 vs OSTO:NEWBRY: -113.10

Newbury Pharmaceuticals AB FCF Margin % Historical Data

The historical data trend for Newbury Pharmaceuticals AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB FCF Margin % Chart

Newbury Pharmaceuticals AB Annual Data

Trend

Aug21

Aug22

Aug23

FCF Margin %

-959.77

-714.27

-234.65

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
FCF Margin %	Get a 7-Day Free Trial									-389.67	-150.21	-128.44	-50.76	-254.45

Competitive Comparison of Newbury Pharmaceuticals AB's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Newbury Pharmaceuticals AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newbury Pharmaceuticals AB's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newbury Pharmaceuticals AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Newbury Pharmaceuticals AB's FCF Margin % falls into.

Newbury Pharmaceuticals AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Newbury Pharmaceuticals AB's FCF Margin for the fiscal year that ended in Aug. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Aug. 2023 )	/	Revenue (A: Aug. 2023 )
	=	-24.089	/	10.266
	=	-234.65 %

Newbury Pharmaceuticals AB's FCF Margin for the quarter that ended in Feb. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Feb. 2024 )	/	Revenue (Q: Feb. 2024 )
	=	-7.977	/	3.135
	=	-254.45 %

Newbury Pharmaceuticals AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.newburypharma.com

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Headlines

No Headlines